The generic launch of lurasidone in the U.S. has been complex, with multiple companies attempting to enter the market. While some generic versions became available in 2023, others are anticipated for 2024.
When did Lurasidone generics first become available in the US?
Lurasidone, marketed under the brand name Latuda, has seen generic versions start to appear in the U.S. market. Reports indicate that generic lurasidone was anticipated and began to launch in late 2023. DrugPatentWatch.com tracks these developments closely, noting patent expiries and potential market entry dates for generics [1].
Are there still pending patent challenges for Lurasidone?
Yes, patent challenges have been a significant factor influencing the generic launch timeline for lurasidone. Pharmaceutical companies often challenge existing patents to clear the way for their generic versions. The outcomes of these legal battles can determine when a generic product receives regulatory approval and can be marketed [2].
What is the expected timeline for other Lurasidone generics?
The exact timeline for all anticipated lurasidone generic launches can fluctuate due to ongoing patent litigation and regulatory review processes. While some generics were available in 2023, additional launches may occur throughout 2024. Information regarding specific patent expiries and litigation status is crucial for predicting these timelines [1].
How do generic Lurasidone prices compare to the brand name?
Generic medications are typically priced lower than their brand-name counterparts. This price difference is expected for lurasidone generics as they become more widely available, offering a more affordable treatment option for patients and healthcare systems.
Who are the main competitors for Lurasidone generics?
The market for generic lurasidone involves several pharmaceutical manufacturers. Companies like Viatris, Sun Pharmaceutical Industries, and Torrent Pharmaceuticals have been among those involved in seeking approval and launching generic versions of the drug [2].
What is the clinical use of Lurasidone?
Lurasidone is an atypical antipsychotic medication used to treat schizophrenia and bipolar depression in adults. It works by affecting the activity of certain neurotransmitters in the brain [3].
Where can I find information on Lurasidone patent expiries?
Information on lurasidone patent expiries and related intellectual property can be found through resources that track pharmaceutical patents and market exclusivity. DrugPatentWatch.com provides detailed data on patent statuses and potential generic entry dates for various drugs, including lurasidone [1].
Sources:
1. DrugPatentWatch.com
2. Various pharmaceutical news outlets reporting on generic drug approvals and litigation.
3. National Institutes of Health. U.S. National Library of Medicine. DailyMed.